These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Role of hormones in pilosebaceous unit development. Deplewski D, Rosenfield RL. Endocr Rev; 2000 Aug; 21(4):363-92. PubMed ID: 10950157 [Abstract] [Full Text] [Related]
6. Two different pathogenetic mechanisms may play a role in acne and in hirsutism. Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Rossi FG, Colonna LM, Sciarra F. Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744 [Abstract] [Full Text] [Related]
13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Farquhar C, Lee O, Toomath R, Jepson R. Cochrane Database Syst Rev; 2003 Nov 15; (4):CD000194. PubMed ID: 14583916 [Abstract] [Full Text] [Related]
18. Pharmacologic modulation of sebaceous gland activity: mechanisms and clinical applications. Clarke SB, Nelson AM, George RE, Thiboutot DM. Dermatol Clin; 2007 Apr 15; 25(2):137-46, v. PubMed ID: 17430751 [Abstract] [Full Text] [Related]
19. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne. Timpatanapong P, Rojanasakul A. J Dermatol; 1997 Apr 15; 24(4):223-9. PubMed ID: 9164062 [Abstract] [Full Text] [Related]